Associations between High-Density Lipoprotein Functionality and Major Adverse Cardiovascular Events in Patients Who Have Undergone Coronary Computed Tomography Angiography

被引:6
作者
Inoue, Hiroko [1 ]
Shiga, Yuhei [2 ]
Norimatsu, Kenji [1 ,2 ]
Tashiro, Kohei [2 ]
Futami, Makito [1 ,2 ]
Suematsu, Yasunori [2 ]
Sugihara, Makoto [2 ]
Nishikawa, Hiroaki [1 ]
Katsuda, Yousuke [1 ]
Miura, Shin-ichiro [1 ,2 ]
机构
[1] Fukuoka Univ, Dept Cardiol, Nishijin Hosp, Fukuoka 8148522, Japan
[2] Fukuoka Univ, Dept Cardiol, Sch Med, Fukuoka 8140180, Japan
基金
美国国家科学基金会;
关键词
high-density lipoprotein; cholesterol efflux capacity; major adverse cardiovascular events; C-REACTIVE PROTEIN; CHOLESTEROL EFFLUX CAPACITY; APOLIPOPROTEIN-A-I; LDL CHOLESTEROL; HDL CHOLESTEROL; HEART-DISEASE; MORTALITY; RISK;
D O I
10.3390/jcm10112431
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study aimed to investigate the associations between high-density lipoprotein (HDL) functionality and major adverse cardiovascular events (MACE) in patients who have undergone coronary computed tomography angiography (CCTA). We performed a prospective cohort study and enrolled 151 patients who underwent CCTA and had a follow-up of up to 5 years. We measured cholesterol efflux capacity (CEC), caspase-3/7 activity and monocyte chemoattractant protein-1 (MCP-1) secretion as bioassays of HDL functionality. The patients were divided into MACE(-) (n = 138) and MACE(+) (n = 13) groups. While there was no significant difference in %CEC, caspase-3/7 activity or MCP-1 secretion between the MACE(-) and MACE(+) groups, total CEC and HDL cholesterol (HDL-C) in the MACE(+) group were significantly lower than those in the MACE(-) group. Total CEC was correlated with HDL-C. A receiver-operating characteristic curve analysis showed that there was no significant difference between the areas under the curves for total CEC and HDL-C. In conclusion, total CEC in addition to HDL-C, but not %CEC, was associated with the presence of MACE. On the other hand, HDL functionality with regard to anti-inflammatory and anti-apoptosis effects was not associated with MACE.
引用
收藏
页数:10
相关论文
共 32 条
  • [1] HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
    Barter, Philip
    Gotto, Antonio M.
    LaRosa, John C.
    Maroni, Jaman
    Szarek, Michael
    Grundy, Scott M.
    Kastelein, John J. P.
    Bittner, Vera
    Fruchart, Jean-Charles
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (13) : 1301 - 1310
  • [2] Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
    Boden, William E.
    Probstfield, Jeffrey L.
    Anderson, Todd
    Chaitman, Bernard R.
    Desvignes-Nickens, Patrice
    Koprowicz, Kent
    McBride, Ruth
    Teo, Koon
    Weintraub, William
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24) : 2255 - 2267
  • [3] INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY
    CASTELLI, WP
    GARRISON, RJ
    WILSON, PWF
    ABBOTT, RD
    KALOUSDIAN, S
    KANNEL, WB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20): : 2835 - 2838
  • [4] Apolipoprotein B-100 and ApoA-II Kinetics as Determinants of Cellular Cholesterol Efflux
    Chan, Dick C.
    Anh Hoang
    Barrett, P. Hugh R.
    Wong, Annett T. Y.
    Nestel, Paul J.
    Sviridov, Dmitri
    Watts, Gerald F.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (09) : E1658 - E1666
  • [5] Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention
    Chew, DP
    Bhatt, DL
    Robbins, MA
    Penn, MS
    Schneider, JP
    Lauer, MS
    Topol, EJ
    Ellis, SG
    [J]. CIRCULATION, 2001, 104 (09) : 992 - 997
  • [6] Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619
  • [7] Regulation of endothelial cell apoptosis in atherothrombosis
    Dimmeler, S
    Haendeler, J
    Zeiher, AM
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (05) : 531 - 536
  • [8] Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease
    Dong, Yan
    Chen, Hengwen
    Gao, Jialiang
    Liu, Yongmei
    Li, Jun
    Wang, Jie
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 136 : 27 - 41
  • [9] Farbstein D, 2012, EXPERT REV CARDIOVAS, V10, P353, DOI [10.1586/erc.11.182, 10.1586/ERC.11.182]
  • [10] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY
    GORDON, T
    CASTELLI, WP
    HJORTLAND, MC
    KANNEL, WB
    DAWBER, TR
    [J]. AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) : 707 - 714